About Me
Hear My Insights
From Lab to Market: AI-Powered Drug Discovery in Action
Colin Murdoch, President of Isomorphic Labs and CBO at Google DeepMind, reveals the blueprint for translating AI's potential into biotech reality. In this exclusive session, he unpacks Isomorphic Labs' journey, showing how the company has bridged the gap between complex algorithms, life-changing drug discovery – and a market-ready business.
Navigating the Next Frontier in AI
As artificial intelligence accelerates, the industry is entering a new era – defined not just by powerful foundation models, but by collaborative tools that can reason, adapt, and assist across every domain. This session will explore why a multi-model future makes sense, why Amazon is building its own foundation models, and what it takes to develop AI systems that are useful, trustworthy, and scalable across diverse industries. Attendees will gain insight into Amazon's evolving AI approach across retail, entertainment, cloud, devices, and more – while exploring the wider challenges and opportunities shaping innovation across industries.